{"cursor":"26205","size":15,"audio":[],"currentlang":"en","article":"\n{{Infobox company |name = Tanox |logo = |type = Public company |traded_as =\n|foundation = Houston, Texas (1986) |location = Houston, Texas, US |key_people =\nNancy Chang Tse Wen Chang |fate = acquired by Genentech (2007) |industry =\nBiopharmaceutical |products = Humanized antibody drugs |revenue = |num_employees\n= |homepage = [http://www.tanox.com/home/home.asp www.tanox.com]\n|}}\n'Tanox' was a biopharmaceutical company based in Houston, Texas. The company was\nfounded by two biomedical research scientists, Nancy T. Chang and Tse Wen Chang\nin March 1986 with $250,000, which was a large part of their family savings at\nthat time. The two Changs had been research managers working with a range of\nmonoclonal antibody projects in Centocor, Inc. based in Malvern, Pennsylvania\nfrom 1981 to 1985. Twombly R. Couple Lead Quest for New\nAllergy Drug. The Scientist January 7, 1991. http://www.the-scientist.com/?articles.view/articleNo/11548/title/Couple-Lead-\nQuest-For-New-Allergy-Drug/. The Changs were recruited by Baylor College\nof Medicine toward the end of 1985 and offered faculty positions in the Division\nof Molecular Virology. Soon after their arrival, they were encouraged by a high-\nranking Baylor official and local business leaders to start a biotech venture in\nHouston. This was in a period of time when the economy of Houston was in slump\nas the result of the collapse of the oil industry.\n\nThe Changs rented a corner of about 2000 square feet in a large empty warehouse\nbuilding on Stella Link Road, located four miles away from the Texas Medical\nCenter, and built laboratories. In 1987, Tanox obtained a $4 million cash\ninfusion from the legendary biotech venture capitalist and investor, Moshe\nAlafi, who was a founding investor of Cetus, Amgen,\nBiogen, and a few other successful biotech companies. Goldhaber N and\nSteuart J. Biotech Industry Guru Moshe Alafi Wins Lifetime Achievement Award\nFrom UC Berkeley. Claremont Creek Alerts March 24, 2012. http://blog.claremontcreek.com/biotech-industry-guru-moshe-alafi-wins-lifetime-\nachievement-award-from-uc-berkeley/. Nancy was the Chairman, President,\nand CEO of Tanox in its 21 year history, while Tse Wen was responsible for\ncreating most of the company's proprietary technology and patents. Tanox's major\ntechnology was based on a series of inventions and a family of dominant patents,\nmost notably those relating to the \"anti-IgE therapy\", The family of anti-IgE patents.\nhttp://www.google.com/patents/US5422258;\nhttp://www.google.com/patents/US5428133;\nhttp://www.google.com/patents/US5449760;\nhttp://www.google.com/patents/US5543144;\nhttp://www.google.com/patents/US5614611. the \"migis concept\", The family of patents relating to the \"migis\" concept.\nhttp://www.google.com/patents/US5091313;\nhttp://www.google.com/patents/US5252467;\nhttp://www.google.com/patents/US5260416;\nhttp://www.google.com/patents/US5292867. and the \"anti-CÎµmX approach\",","linknr":503,"url":"Tanox","recorded":1376418704,"links":["/w/index.php?title=Tanox&action=edit","/w/index.php?title=Tanox&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Tanox","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","/wiki/Wikipedia:No_original_research","//en.wikipedia.org/w/index.php?title=Tanox&action=edit","/wiki/Wikipedia:Verifiability","/wiki/Wikipedia:INCITE","/wiki/File:Tanox-logo.PNG","//upload.wikimedia.org/wikipedia/en/6/63/Tanox-logo.PNG","/wiki/Types_of_business_entity","/wiki/Public_company","/wiki/Ticker_symbol","/wiki/NASDAQ","/wiki/Biopharmaceutical","/wiki/Genentech","/wiki/Houston,_Texas","/wiki/United_States","/wiki/Nancy_T._Chang","/wiki/Humanized_antibody","http://www.tanox.com/home/home.asp","/wiki/Biopharmaceutical","/wiki/Houston,_Texas","/wiki/Nancy_T._Chang","/wiki/Monoclonal_antibody","/wiki/Centocor,_Inc.","/wiki/Malvern,_Pennsylvania","#cite_note-The_Scientist-1","/wiki/Baylor_College_of_Medicine","#cite_note-The_Scientist-1","/wiki/Texas_Medical_Center","#cite_note-The_Scientist-1","/wiki/Cetus","/wiki/Amgen","/wiki/Biogen","#cite_note-2","#cite_note-anti-IgE_patents-3","#cite_note-the_migis_patents-4","#cite_note-the_anti-C.CE.B5mX_patents-5","/wiki/Humanized_antibody","/wiki/Immunoglobulin_E","/wiki/B_lymphocyte","/wiki/Initial_public_offering","/wiki/NASDAQ","#cite_note-6","#cite_note-Tanox_2006_Report-7","/wiki/Genentech","#cite_note-Genentech_aquisition-8","/wiki/Hoffmann%E2%80%93La_Roche","#cite_note-Tanox_2006_Report-7","#cite_note-Genentech_aquisition-8","#cite_note-9","#cite_note-Roche_Investor_Day_2012-10","/wiki/Xolair","/wiki/Omalizumab","/wiki/TNX-901","/wiki/Talizumab","/wiki/TNX-355","/wiki/Ibalizumab","/wiki/AIDS","/wiki/TNX-650","/wiki/Lebrikizumab","/wiki/Interleukin-13","/wiki/Complement_system","#cite_note-Roche_Investor_Day_2012-10","/wiki/Quilizumab","#cite_note-Roche_Investor_Day_2012-10","#The_anti-IgE_program","#Antibody_therapeutics","#Other_major_technologies","#References","#External_links","/w/index.php?title=Tanox&action=edit&section=1","/w/index.php?title=Tanox&veaction=edit&section=1","/wiki/High_affinity_IgE_receptor","/wiki/Mast_cells","/wiki/Basophils","/wiki/Anaphylactic","#cite_note-The_Scientist-1","#cite_note-anti-IgE_patents-3","#cite_note-pmid1369991-11","#cite_note-pmid8362344-12","#cite_note-The_Scientist-1","/wiki/Ciba-Geigy","/wiki/Sandoz","/wiki/Novartis","#cite_note-13","/wiki/TNX-901","/wiki/Talizumab","/wiki/Bioreactor","/wiki/Investigational_new_drug","/wiki/Food_and_Drug_Administration","/wiki/Southampton,_England","#cite_note-pmid9062345-14","/wiki/Allergic_rhinitis","#cite_note-pmid9433396-15","#cite_note-16","#cite_note-17","#cite_note-Tripartite_Agreement-18","/wiki/Omalizumab","#cite_note-Tripartite_Agreement-18","/wiki/Xolair","/wiki/Asthma","/wiki/European_Union","/w/index.php?title=Tanox&action=edit&section=2","/w/index.php?title=Tanox&veaction=edit&section=2","/wiki/Humanized_antibody","/wiki/Omalizumab","/wiki/Xolair","/wiki/TNX-901","/wiki/Talizumab","#cite_note-pmid12637608-19","#cite_note-20","#cite_note-21","/wiki/Immunoglobulin","/wiki/B-cell_receptor","#cite_note-pmid1370037-22","#cite_note-pmid1727861-23","/wiki/American_Association_of_Immunologists","/wiki/National_Tsing_Hua_University","/wiki/Monoclonal_antibodies","#cite_note-pmid12218370-24","#cite_note-pmid20458139-25","/wiki/Quilizumab","#cite_note-26","#cite_note-27","/wiki/TNX-355","/wiki/Ibalizumab","/wiki/CD4","/wiki/AIDS","/wiki/Human_immunodeficiency_virus","/wiki/HIV","/wiki/Biogen","#cite_note-pmid19015347-28","#cite_note-29","#cite_note-30","/wiki/TNX-650","/wiki/Lebrikizumab","/wiki/Interleukin_13","#cite_note-pmid21812663-31","#cite_note-32","#cite_note-33","#cite_note-34","/w/index.php?title=Tanox&action=edit&section=3","/w/index.php?title=Tanox&veaction=edit&section=3","/wiki/Antibody_matrix","#cite_note-35","#cite_note-pmid6606681-36","/wiki/Antibody_microarray","/wiki/Microarray","#cite_note-pmid7765290-37","/wiki/CD3_(immunology)","/wiki/CD4","/wiki/CD8","/wiki/AIDS","/wiki/Human_immunodeficiency_virus","/wiki/HIV","/wiki/B_lymphocyte","/wiki/PCR","#cite_note-38","/wiki/Polymerase_chain_reaction","/w/index.php?title=Tanox&action=edit&section=4","/w/index.php?title=Tanox&veaction=edit&section=4","#cite_ref-The_Scientist_1-0","#cite_ref-The_Scientist_1-1","#cite_ref-The_Scientist_1-2","#cite_ref-The_Scientist_1-3","#cite_ref-The_Scientist_1-4","http://www.the-scientist.com/?articles.view/articleNo/11548/title/Couple-Lead-Quest-For-New-Allergy-Drug/","#cite_ref-2","http://blog.claremontcreek.com/biotech-industry-guru-moshe-alafi-wins-lifetime-achievement-award-from-uc-berkeley/","#cite_ref-anti-IgE_patents_3-0","#cite_ref-anti-IgE_patents_3-1","http://www.google.com/patents/US5422258","http://www.google.com/patents/US5428133","http://www.google.com/patents/US5449760","http://www.google.com/patents/US5543144","http://www.google.com/patents/US5614611","#cite_ref-the_migis_patents_4-0","http://www.google.com/patents/US5091313","http://www.google.com/patents/US5252467","http://www.google.com/patents/US5260416","http://www.google.com/patents/US5292867","#cite_ref-the_anti-C.CE.B5mX_patents_5-0","http://www.google.com/patents/US5254671","http://www.google.com/patents/US5274075","http://www.google.com/patents/US5342924","#cite_ref-6","http://www.prnewswire.co.uk/news-releases/tanox-inc-completes-us2442-million-initial-public-offering-153810095.html","#cite_ref-Tanox_2006_Report_7-0","#cite_ref-Tanox_2006_Report_7-1","http://biz.yahoo.com/e/070316/tnox10-k.html","#cite_ref-Genentech_aquisition_8-0","#cite_ref-Genentech_aquisition_8-1","http://www.gene.com/media/press-releases/10167/2006-11-09/genentech-announces-agreement-to-acquire","#cite_ref-9","http://www.forbes.com/2006/11/10/genentech-tanox-acquisition-markets-equity-cx_mk_1110markets03.html","#cite_ref-Roche_Investor_Day_2012_10-0","#cite_ref-Roche_Investor_Day_2012_10-1","#cite_ref-Roche_Investor_Day_2012_10-2","http://www.roche.com/investors/ir_agenda/ir_day-2012.htm","#cite_ref-pmid1369991_11-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fnbt0290-122","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/1369991","#cite_ref-pmid8362344_12-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1007%2FBF00204626","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/8362344","#cite_ref-13","http://contracts.onecle.com/tanox/ciba-geigy.rd.1990.05.11.shtml","#cite_ref-pmid9062345_14-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1172%2FJCI119252","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/9062345","#cite_ref-pmid9433396_15-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2FS0009-9236%2897%2990087-4","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/9433396","#cite_ref-16","http://business.highbeam.com/410545/article-1G1-16816180/drug-war","#cite_ref-17","http://www.nytimes.com/2003/03/13/business/wrangling-may-delay-peanut-allergy-drug.html?pagewanted=all&src=pm","#cite_ref-Tripartite_Agreement_18-0","#cite_ref-Tripartite_Agreement_18-1","http://www.sec.gov/Archives/edgar/data/1099414/000119312504083427/dex101.htm","#cite_ref-pmid12637608_19-0","http://content.nejm.org/cgi/content/abstract/348/11/986","/wiki/N._Engl._J._Med.","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMoa022613","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12637608","#cite_ref-20","http://news.sciencemag.org/sciencenow/2003/03/10-02.html?ref=hp","#cite_ref-21","http://www.dailymail.co.uk/health/article-172357/Drug-beat-nut-allergy.html","#cite_ref-pmid1370037_22-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fnbt0191-53","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/1370037","#cite_ref-pmid1727861_23-0","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/1727861","#cite_ref-pmid12218370_24-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1159%2F000063860","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12218370","#cite_ref-pmid20458139_25-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1172%2FJCI40141","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/20458139","#cite_ref-26","http://www.roche.com/investors/ir_agenda/ir_day-2012.htm","#cite_ref-27","http://clinicaltrial.gov/ct2/show/NCT01582503?term=MEMP1972A&rank=1","#cite_ref-pmid19015347_28-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1128%2FAAC.00942-08","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/19015347","#cite_ref-29","http://www.mdlinx.com/pharma-news/news-article.cfm/2208067/","#cite_ref-30","http://www.taimedbiologics.com/en/info/TMB355.aspx","#cite_ref-pmid21812663_31-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMoa1106469","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/21812663","#cite_ref-32","http://www.google.com/patents/US8124090","#cite_ref-33","http://www.thefreelibrary.com/Tanox%27s+Anti-Factor+D+Antibody+Reduces+Systemic+Inflammation+in+An...-a076923261","#cite_ref-34","http://www.clinicaltrials.gov/ct2/show/NCT01229215?term=FCFD4514S&recr=Open&phase=1&rank=1","#cite_ref-35","http://www.google.com/patents/US4591570","http://www.google.com/patents/US4829010","http://www.google.com/patents/US5100777","#cite_ref-pmid6606681_36-0","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/6606681","#cite_ref-pmid7765290_37-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fnbt0393-291","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/7765290","#cite_ref-38","http://www.google.com/patents/US5213960","http://www.google.com/patents/US5256542","http://www.google.com/patents/US5326696","/w/index.php?title=Tanox&action=edit&section=5","/w/index.php?title=Tanox&veaction=edit&section=5","http://www.tanox.com/home/home.asp","/wiki/Template:Pharmaceutical_companies_of_the_United_States","/wiki/Template_talk:Pharmaceutical_companies_of_the_United_States","//en.wikipedia.org/w/index.php?title=Template:Pharmaceutical_companies_of_the_United_States&action=edit","/wiki/Category:Pharmaceutical_companies_of_the_United_States","/wiki/Abbott_Laboratories","/wiki/Acorda_Therapeutics","/wiki/Actavis","/wiki/Aderis_Pharmaceuticals","/wiki/Adolor_Corporation","/wiki/Alcon","/wiki/Alexion_Pharmaceuticals","/wiki/Alkermes_(company)","/wiki/Allergan","/wiki/Alza","/wiki/Amgen","/wiki/Amylin_Pharmaceuticals","/wiki/ARIAD_Pharmaceuticals","/wiki/ARYx_Therapeutics","/wiki/Avax_Technologies","/wiki/Barr_Pharmaceuticals","/wiki/Baxter_International","/wiki/BioCryst_Pharmaceuticals","/wiki/Biogen_Idec","/wiki/Biolex","/wiki/Biovest","/wiki/Biovista","/wiki/Bradley_Pharmaceuticals","/wiki/Bristol-Myers_Squibb","/wiki/CancerVax","/wiki/Century_Pharmaceuticals","/wiki/Cephalon","/wiki/Ceragenix_Pharmaceuticals","/wiki/Combe_Incorporated","/wiki/Cortex_Pharmaceuticals","/wiki/CoTherix","/wiki/Covance","/wiki/Covidien","/wiki/Cutter_Laboratories","/wiki/CytoSport","/wiki/CytRx","/wiki/Danco_Laboratories","/wiki/DNAPrint_Genomics","/wiki/EPIX_Pharmaceuticals_Inc","/wiki/Eli_Lilly_and_Company","/wiki/Elorac","/wiki/Endo_Pharmaceuticals","/wiki/Ethicon_Endo-Surgery","/wiki/Ethicon_Inc.","/wiki/Forest_Laboratories","/wiki/Galena_Biopharma","/wiki/GenVec","/wiki/Genentech","/wiki/Genta_(company)","/wiki/Gilead_Sciences","/wiki/Hospira","/wiki/ImClone_Systems","/wiki/Institute_for_OneWorld_Health","/wiki/ISTA_Pharmaceuticals","/wiki/Ivax_Corporation","/wiki/Janssen_Biotech","/wiki/Johnson_%26_Johnson","/wiki/Kinetic_Concepts","/wiki/King_Pharmaceuticals","/wiki/Kinray","/wiki/KV_Pharmaceutical","/wiki/Leiner_Health_Products","/wiki/Mallinckrodt","/wiki/Martek_Biosciences_Corporation","/wiki/S._E._Massengill_Company","/wiki/McKesson_Corporation","/wiki/McNeil_Laboratories","/wiki/Melior_Discovery","/wiki/Mentholatum","/wiki/Merck_%26_Co.","/wiki/Miles_Laboratories","/wiki/Mylan","/wiki/Myriad_Genetics","/wiki/Nereus_Pharmaceuticals","/wiki/Northwest_Biotherapeutics","/wiki/Norwich_Pharmaceuticals","/wiki/Nuvelo","/wiki/Organon_International","/wiki/Ortho_Pharmaceutical","/wiki/Ortho-McNeil_Pharmaceutical","/wiki/OSI_Pharmaceuticals","/wiki/Ovation_Pharmaceuticals","/wiki/Panacos_Pharmaceuticals","/wiki/Par_Pharmaceutical","/wiki/Parke-Davis","/wiki/Perrigo","/wiki/Pfizer","/wiki/Pharmaceutical_Product_Development","/wiki/Prasco_Laboratories","/wiki/Procter_%26_Gamble","/wiki/Proteon_Therapeutics","/wiki/Purdue_Pharma","/wiki/Qualitest","/wiki/Quark_Pharmaceuticals","/wiki/Regeneron","/wiki/Repros_Therapeutics","/wiki/Respa_Pharmaceuticals","/wiki/Rib-X_Pharmaceuticals","/wiki/Sarepta_Therapeutics","/wiki/Savage_Laboratories","/wiki/Schering-Plough","/wiki/G._D._Searle_%26_Company","/wiki/Smith,_Kline_%26_French","/wiki/Spectrum_Pharmaceuticals","/wiki/Sterling_Drug","/wiki/TAP_Pharmaceutical_Products","/wiki/Tec_Laboratories","/wiki/Teva_Pharmaceutical_Industries","/wiki/Tiens_Biotech_Group","/wiki/Titan_Pharmaceuticals","/wiki/Trevena_Inc","/wiki/Trubion","/wiki/Upjohn","/wiki/Upsher-Smith_Laboratories","/wiki/Valeant_Pharmaceuticals","/wiki/Ventria_Bioscience","/wiki/Vertex_Pharmaceuticals","/wiki/Verus_Pharmaceuticals","/wiki/Vion_Pharmaceuticals,_Inc.","/wiki/ViroPharma","/wiki/Vital_Pharmaceuticals","/wiki/West_Pharmaceutical_Services","/wiki/Wyeth","/wiki/Zonite_Products_Corporation","/wiki/List_of_pharmaceutical_companies","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Tanox&oldid=563958956","/wiki/Help:Category","/wiki/Category:Pharmaceutical_companies_of_the_United_States","/wiki/Category:Companies_based_in_Houston,_Texas","/wiki/Category:Articles_that_may_contain_original_research_from_July_2013","/wiki/Category:All_articles_that_may_contain_original_research","/w/index.php?title=Special:UserLogin&returnto=Tanox&type=signup","/w/index.php?title=Special:UserLogin&returnto=Tanox","/wiki/Tanox","/wiki/Talk:Tanox","#","/wiki/Tanox","/w/index.php?title=Tanox&action=edit","/w/index.php?title=Tanox&veaction=edit","/w/index.php?title=Tanox&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Tanox","/wiki/Special:RecentChangesLinked/Tanox","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Tanox&oldid=563958956","/w/index.php?title=Tanox&action=info","//www.wikidata.org/wiki/Q7683742","/w/index.php?title=Special:Cite&page=Tanox&id=563958956","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Tanox","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Tanox&oldid=563958956&writer=rl","/w/index.php?title=Tanox&printable=yes","//zh.wikipedia.org/wiki/Tanox","#","//www.wikidata.org/wiki/Q7683742#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Tanox","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["immunology"],"pdf":[],"categories":["Pharmaceutical companies of the United States","Companies based in Houston, Texas"],"headings":["The anti-IgE program","Antibody therapeutics","Other major technologies","References","External links"],"image":["//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//upload.wikimedia.org/wikipedia/en/6/63/Tanox-logo.PNG","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["cd3","immunology"]],"members":["cd3"],"related":["Public_company","Houston,_Texas","United_States","Nancy_T._Chang","Genentech","Biopharmaceutical","Humanized_antibody","Biopharmaceutical","Houston,_Texas","Nancy_T._Chang","Monoclonal_antibody","Centocor,_Inc.","Malvern,_Pennsylvania","Baylor_College_of_Medicine","Texas_Medical_Center","Cetus","Amgen","Biogen","Humanized_antibody","Immunoglobulin_E","B_lymphocyte","Initial_public_offering","NASDAQ","Genentech","Hoffmann–La_Roche","Xolair","Omalizumab","TNX-901","Talizumab","TNX-355","Ibalizumab","AIDS","TNX-650","Lebrikizumab","Interleukin-13","Complement_system","Quilizumab","High_affinity_IgE_receptor","Mast_cells","Basophils","Anaphylactic","Ciba-Geigy","Sandoz","Novartis","TNX-901","Talizumab","Bioreactor","Investigational_new_drug","Food_and_Drug_Administration","Southampton,_England","Allergic_rhinitis","Omalizumab","Xolair","Asthma","European_Union","Humanized_antibody","Omalizumab","Xolair","TNX-901","Talizumab","Immunoglobulin","B-cell_receptor","American_Association_of_Immunologists","National_Tsing_Hua_University","Monoclonal_antibodies","Quilizumab","TNX-355","Ibalizumab","CD4","AIDS","Human_immunodeficiency_virus","HIV","Biogen","TNX-650","Lebrikizumab","Interleukin_13","Antibody_matrix","Antibody_microarray","Microarray","CD3_(immunology)","CD4","CD8","AIDS","Human_immunodeficiency_virus","HIV","B_lymphocyte","PCR","Polymerase_chain_reaction"]}